Monitor for any definitive agreement, partnership, or acquisition in the Agentic AI space; without concrete steps, this remains a non-event. The company's existing cash burn and clinical pipeline remain unchanged.
Price Chart
Executive Summary
SciSparc announced a strategic shift toward Agentic AI-powered technologies, including cybersecurity and finance, while maintaining its clinical-stage cannabinoid pharmaceutical pipeline. The press release is entirely forward-looking with no concrete transactions, revenues, or milestones, and explicitly states there is no assurance of any resulting deal or revenue.
Key Facts
- SciSparc is shifting strategic focus toward Agentic AI technologies (cybersecurity and finance).
- No specific transaction, commercial agreement, or revenue-generating activity has been identified or announced.
- The company continues its existing clinical-stage cannabinoid pharmaceutical programs (SCI-110, SCI-210) through subsidiary NeuroThera.
- The press release contains only forward-looking statements and disclaims any obligation to update them.
Financial Impact
No financial figures disclosed; no deal value, revenue, or costs provided.
Risk Factors
- No assurance that the strategic shift will result in any transaction or revenue.
- Dilution risk if the company raises capital to fund AI initiatives.
- Execution risk in pivoting from clinical-stage pharma to AI technologies.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3381509 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $1.29 | awaiting T+5 | — | $0.8500 (+34.08%) |
Oct 23, 2026 4d ago | 6-K | $1.09 | awaiting T+5 | — | $0.8500 (−22.02%) |
Oct 22, 2026 5d ago | Press Release | $1.20 | awaiting T+5 | — | $0.8500 (−29.17%) |
Oct 15, 2026 12d ago | 6-K | $2.00 $1.20 | ▲ +40.00% | ▲ +38.99% | $0.8500 (+57.50%) |
Oct 15, 2026 12d ago | 6-K | $2.00 $1.20 | ▼ −40.00% | ▼ −38.99% | $0.8500 (−57.50%) |
Oct 15, 2026 12d ago | Press Release | $2.00 $1.20 | ▼ −40.00% | ▼ −38.99% | $0.8500 (−57.50%) |
Oct 7, 2026 20d ago | 6-K | $4.64 $3.63 | ▼ −21.77% | ▼ −20.79% | $0.8500 (−81.68%) |
Sep 30, 2026 27d ago | 6-K | $4.55 $4.43 | ▲ +2.64% | ▲ +3.94% | $0.8500 (+81.32%) |
Sep 24, 2026 4w ago | 6-K | $5.39 $4.55 | ▼ −15.58% | ▼ −15.17% | $0.8500 (−84.23%) |
Sep 23, 2026 4w ago | Press Release | $5.01 $4.72 | ▼ −5.79% | ▼ −5.11% | $0.8500 (−83.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers